DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.

Camacho, Kathryn M

DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society 05 2016 - 154-162 p. digital

Publication Type: Journal Article

1873-4995

10.1016/j.jconrel.2016.03.027 doi


Animals
Antibiotics, Antineoplastic--administration & dosage
Antimetabolites, Antineoplastic--administration & dosage
Cell Line
Cell Line, Tumor
Doxorubicin--administration & dosage
Drug Combinations
Female
Fluorouracil--administration & dosage
Humans
Liposomes
Mice, Inbred BALB C
Neoplasms--drug therapy
Polyethylene Glycols--chemistry
Tryptophan--chemistry
Tumor Burden--drug effects